USA flag logo/image

An Official Website of the United States Government

Potency, Efficacy and Standardization of a Whole Killed IHN Virus Vaccine

Award Information

Agency:
Department of Agriculture
Branch:
N/A
Award ID:
62050
Program Year/Program:
2005 / SBIR
Agency Tracking Number:
2003-00484
Solicitation Year:
N/A
Solicitation Topic Code:
N/A
Solicitation Number:
N/A
Small Business Information
Maine BioTek, Inc.
259 MAIN STREET Suite 208 WINTERPORT, ME 04496 0408
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 2
Fiscal Year: 2005
Title: Potency, Efficacy and Standardization of a Whole Killed IHN Virus Vaccine
Agency: USDA
Contract: 2005-33610-16080
Award Amount: $296,000.00
 

Abstract:

The salmon and to a lesser extent the trout aquaculture industries in North America consider infectious hematopoietic necrosis virus a major threat to the current and future economic viability and sustainable growth of the industry. As such, development of an efficacious IHN virus vaccine has been identified as top priority of both government and industry organizations in the United States and Canada. The ultimate goal of this project (Phase I-III) is to develop a vaccine for the control of infectious hematopoietic necrosis (IHN) disease of salmon and trout. The specific technical goal and deliverable product of the Phase II project is a pre-commercial IHN virus vaccine prototype. The work plan will address five primary topics related to vaccine performance: vaccine (1) preparation, (2) formulation, (3) potency, (4) safety and (5) efficacy.

Principal Investigator:

Eric D. Anderson
2072234662
mainebiotek@hotmail.com

Business Contact:

Eric D. Anderson
2072234662
mainebiotek@hotmail.com
Small Business Information at Submission:

Maine BioTek, Inc.
P.O. Box 408, 259 Main Street Winterport, ME 04496

EIN/Tax ID:
DUNS: N/A
Number of Employees: N/A
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No